COMMUNIQUÉS West-GlobeNewswire

Innovate Biopharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Operational Progress Updates on March 19, 2019
19/03/2019
Investor conference call at 8AM ET and earnings press release scheduled for before the market opens on March 19, 2019 RALEIGH, N.C., March 18, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) ( [...]
Immutep to Present IMP761 Preclinical Results in Global Webcast
19/03/2019
SYDNEY, Australia, March 18, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]
Auxly to Report 2018 Financial Results on March 29, 2019
18/03/2019
VANCOUVER, British Columbia, March 18, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") today announced that it plans to report its fourth quarter and full fiscal year 2018 [...]
CORRECTION - IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 22, 2019 – Conference Call to Follow on March 25, 2019
18/03/2019
SAINT LAURENT, Quebec, March 18, 2019 (GLOBE NEWSWIRE) -- In a release issued under a similar headline earlier today by IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT), please note that the financial results [...]
Scholar Rock Reports Full Year 2018 Financial Results and Highlights Business Progress
18/03/2019
Initiated and Progressed Phase 1 Clinical Trial of SRK-015 in Healthy Volunteers, Transitioning to a Clinical-Stage Company Presented Compelling Preclinical Data from the SRK-181 Cancer Immunotherapy Program at the [...]
RavenQuest Completes Non-Brokered Private Placement
18/03/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, March [...]
aTyr Pharma to Announce Fourth Quarter and Full Year 2018 Financial Results on March 25th
18/03/2019
Company to host conference call and webcast at 5pm EDT / 2pm PDT SAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of [...]
Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
18/03/2019
On track to initiate Phase 3 VITAL™ trial for treatment of RDEB in mid-2019; EB-101 to be manufactured in-house Manufacturing scaled to support AAV based programs; GMP readiness expected 2H19 Investor conference call on [...]
Dermira Announces Proposed Public Offering of Common Stock
18/03/2019
MENLO PARK, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Syneos Health Reports Fourth Quarter and Full Year 2018 Results
18/03/2019
Highlights GAAP total revenue of $1.15 billion and $4.39 billion for the fourth quarter and year ended December 31, 2018, respectively. Adjusted service revenue under ASC 606 of $1.15 billion and $4.40 billion for the [...]
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
18/03/2019
CORAL GABLES, Fla., March 18, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
resTORbio, Inc. Announces Proposed Public Offering of Common Stock
18/03/2019
BOSTON, March 18, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. ("resTORbio" or the "Company") (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to [...]
Additional Real-World Data Show a Significant Risk Increase in Cardiovascular Events in People with Elevated Triglyceride Levels
18/03/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, March 18, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, announced today that real-world data [...]
Opiant Pharmaceuticals to Report Fiscal 2018 Financial Results and Host Conference Call and Webcast on Thursday, March 21
18/03/2019
SANTA MONICA, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced [...]
electroCore to Announce Fourth Quarter and Year Ended December 31, 2018 Financial Results on Wednesday, March 27
18/03/2019
Conference Call to be Held at 4:30pm Eastern Time BASKING RIDGE, N.J., March 18, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it will [...]
Dynavax Exercises Option for $75 Million in Non-Dilutive Debt
18/03/2019
Proceeds to fund HEPLISAV-B® commercialization activities and completion of ongoing immuno-oncology studies BERKELEY, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today [...]
IRIDEX to Present at the Spring Investor Summit
18/03/2019
MOUNTAIN VIEW, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming Spring Investor Summit in New York, NY. Chairman and CEO William [...]
Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results
18/03/2019
CANTON, Mass. , March 18, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
Novavax Reports Fourth Quarter and Year-End 2018 Financial Results
18/03/2019
Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md., March 18, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth [...]

Pages